Shares of Avacta Group Plc (OTCMKTS:AVCTF – Get Free Report) fell 13.5% during trading on Monday . The company traded as low as $0.45 and last traded at $0.45. 2,500 shares were traded during mid-day trading, an increase of 7% from the average session volume of 2,343 shares. The stock had previously closed at $0.52.
Avacta Group Price Performance
The business’s 50-day moving average price is $0.42 and its 200 day moving average price is $0.52.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Read More
- Five stocks we like better than Avacta Group
- How to find penny stocks to invest and trade
- These 3 Undervalued Stocks Could Surge as Value Rotation Nears
- What is a penny stock? A comprehensive guide
- Tilray Shares Blazing: What’s Behind the 55% Rally This Month?
- What Are Growth Stocks and Investing in Them
- 3 Retail Stocks to Watch as Back-to-School Spending Ramps Up
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
